triazoles has been researched along with Somatoform Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khouzam, HR | 1 |
| Allen, L; Escobar, J; Hamer, RM; Lauritano, M; Menza, M; Ostella, F; Warman, M | 1 |
1 review(s) available for triazoles and Somatoform Disorders
| Article | Year |
|---|---|
The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
Topics: Antidepressive Agents, Second-Generation; Biological Availability; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Piperazines; Somatoform Disorders; Treatment Outcome; Triazoles | 2000 |
1 trial(s) available for triazoles and Somatoform Disorders
| Article | Year |
|---|---|
Treatment of somatization disorder with nefazodone: a prospective, open-label study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatoform Disorders; Treatment Outcome; Triazoles | 2001 |